Quantitative interactomics in primary T cells unveils TCR signal diversification extent and dynamics

Guillaume Voisinne1, Kristof Kersse1, Karima Chaoui2

  • 1Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université, INSERM, CNRS, Marseille, France.

Nature Immunology
|October 9, 2019
PubMed

Insights

This study maps the T cell receptor (TCR) signalosome, revealing 277 proteins and 366 interactions. Understanding this network helps predict how protein changes impact T cell signaling.

Area of Science:

  • Immunology
  • Molecular Biology
  • Systems Biology

Background:

  • T cell activation via the T cell receptor (TCR) initiates complex signaling cascades.
  • The precise composition and dynamics of these signaling complexes (signalosomes) remain incompletely understood at a systems level.

Purpose of the Study:

  • To comprehensively map the protein composition and interactions within the TCR signalosome.
  • To analyze the dynamics of signalosome assembly upon TCR engagement.
  • To provide a quantitative framework for understanding TCR signal transduction.

Main Methods:

  • Primary CD4+ T cells were isolated from gene-targeted mice expressing tagged TCR-signaling proteins.
  • Affinity purification coupled with mass spectrometry (AP-MS) was employed to identify interacting proteins.
  • Quantitative analysis integrated protein abundance and interaction stoichiometry.

Main Results:

  • The TCR signal-transduction network comprises at least 277 unique proteins.
  • A total of 366 high-confidence protein-protein interactions within the signalosome were identified.
  • Extensive signal diversification occurs at the plasma membrane level during TCR engagement.
  • Quantitative data allows prediction of the impact of single protein perturbations on the network.

Conclusions:

  • This study presents the first systems-level analysis of the TCR signalosome.
  • The findings reveal the complexity and compartmentalization of TCR signaling.
  • The quantitative framework provides novel insights into T cell activation mechanisms and potential therapeutic targets.